Zobrazeno 1 - 10
of 16
pro vyhledávání: '"antimicrobial drug resistant"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chieh-Liang Wu, Shih-Chi Ku, Kuang-Yao Yang, Wen-Feng Fang, Chih-Yen Tu, Chang-Wen Chen, Kuo-Hsuan Hsu, Wen-Chien Fan, Meng-Chih Lin, Wei Chen, Chih-Ying Ou, Chong-Jen Yu
Publikováno v:
Journal of the Formosan Medical Association, Vol 112, Iss 1, Pp 31-40 (2013)
Community-acquired pneumonia (CAP) and healthcare-associated pneumonia (HCAP) may be caused by potential antimicrobial drug-resistant (PADR) microbes. The aims of this study were to evaluate the incidences and risk factors associated with PADR microb
Externí odkaz:
https://doaj.org/article/4d6301e2625b45f68186089e9ece5d28
Autor:
Masahiro Suzuki, Kazuhiro Yamada, Miki Nagao, Etsuko Aoki, Masakado Matsumoto, Tatsuya Hirayama, Hiroaki Yamamoto, Reiji Hiramatsu, Satoshi Ichiyama, Yoshitsugu Iinuma
Publikováno v:
Emerging Infectious Diseases, Vol 17, Iss 10, Pp 1917-1920 (2011)
We tested 259 methicillin-resistant Staphylococcus aureus isolates and 2 USA300 ATCC type strains for susceptibility to bacitracin and neomycin contained in over-the-counter antibacterial ointments. Resistance to both bacitracin and neomycin was foun
Externí odkaz:
https://doaj.org/article/1e13114a4f21467bb2e07480dc299c01
Autor:
Davina Campbell, Jacqueline Hurd, Robert D. Kirkcaldy, Julian E. Grass, Amelia Bicknese, Anna Bowen
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 22, Iss 9, Pp 1613-1616 (2016)
Emerging Infectious Diseases, Vol 22, Iss 9, Pp 1613-1616 (2016)
These men were 3–77 times more likely than other persons to have shigellae resistant to >1 key drugs.
Shigella spp. cause ≈500,000 illnesses in the United States annually, and resistance to ciprofloxacin, ceftriaxone, and azithromycin is eme
Shigella spp. cause ≈500,000 illnesses in the United States annually, and resistance to ciprofloxacin, ceftriaxone, and azithromycin is eme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c08fa17942f445162fa2454e67b71d9
http://europepmc.org/articles/PMC4994375
http://europepmc.org/articles/PMC4994375
Autor:
Barbara E. Mahon, Jason P. Folster, Weidong Gu, Felicita Medalla, Michael C. Judd, Patricia M. Griffin, Robert M. Hoekstra
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 23, Iss 1, Pp 29-37 (2017)
Emerging Infectious Diseases, Vol 23, Iss 1, Pp 29-37 (2017)
Salmonella infections are a major cause of illness in the United States. The antimicrobial agents used to treat severe infections include ceftriaxone, ciprofloxacin, and ampicillin. Antimicrobial drug resistance has been associated with adverse clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b1332358f29ab98263510b60fa2c74
https://doi.org/10.3201/eid2301.160771
https://doi.org/10.3201/eid2301.160771
Autor:
James Collins, James T. Rudrik, Sanjana Mukherjee, Brian A. Snyder, Shannon D. Manning, Chase M. Anderson, Rebekah E. Mosci
Publikováno v:
Emerging Infectious Diseases, Vol 23, Iss 9, Pp 1609-1611 (2017)
Emerging Infectious Diseases
Emerging Infectious Diseases
High frequencies of antimicrobial drug resistance were observed in O157 and non-O157 Shiga toxin-producing E. coli strains recovered from patients in Michigan during 2010-2014. Resistance was more common in non-O157 strains and independently associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cd0e7c0499911613159eff819bb48b0
https://doi.org/10.3201/eid2309.170523
https://doi.org/10.3201/eid2309.170523
Publikováno v:
Emerging Infectious Diseases 24 (2018) 9
Emerging Infectious Diseases, 24(9), 1609-1616
Emerging Infectious Diseases, 24, 1609-1616
Emerging Infectious Diseases
Emerging Infectious Diseases, 24, 9, pp. 1609-1616
Emerging Infectious Diseases, Vol 24, Iss 9, Pp 1609-1616 (2018)
Emerging Infectious Diseases, 24(9), 1609-1616
Emerging Infectious Diseases, 24, 1609-1616
Emerging Infectious Diseases
Emerging Infectious Diseases, 24, 9, pp. 1609-1616
Emerging Infectious Diseases, Vol 24, Iss 9, Pp 1609-1616 (2018)
Many countries have implemented infection control measures directed at carriers of multidrug-resistant organisms. To explore the ethical implications of these measures, we analyzed 227 consultations about multidrug resistance and compared them with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2808ad3c86479ddbb5ec37ab8c2009f6
https://research.wur.nl/en/publications/ethics-of-infection-control-measures-for-carriers-of-antimicrobia
https://research.wur.nl/en/publications/ethics-of-infection-control-measures-for-carriers-of-antimicrobia
Autor:
Wei Chen, Chong-Jen Yu, Chih Ying Ou, Meng-Chih Lin, Chih Yen Tu, Chieh Liang Wu, Wen Chien Fan, Kuo-Hsuan Hsu, Chang Wen Chen, Shih-Chi Ku, Wen-Feng Fang, Kuang Yao Yang
Publikováno v:
Journal of the Formosan Medical Association, Vol 112, Iss 1, Pp 31-40 (2013)
Background/Purpose Community-acquired pneumonia (CAP) and healthcare-associated pneumonia (HCAP) may be caused by potential antimicrobial drug-resistant (PADR) microbes. The aims of this study were to evaluate the incidences and risk factors associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01bad471f55551cad90c5f7c02361050
Autor:
Clarissa Willers, Chrisna Gouws, Josias H. Hamman, Lissinda H. Du Plessis, Johannes F. Wentzel
Introduction: Microbial resistance against antibiotics is a serious threat to the effective treatment of infectious diseases. Several mechanisms exist through which microorganisms can develop resistance against antimicrobial drugs, of which the overe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcd3b5b8e5170cb4129e809ed686c68a
Autor:
Tatsuya Hirayama, Satoshi Ichiyama, Hiroaki Yamamoto, Masakado Matsumoto, Etsuko Aoki, Masahiro Suzuki, Yoshitsugu Iinuma, Kazuhiro Yamada, Miki Nagao, Reiji Hiramatsu
Publikováno v:
Emerging Infectious Diseases, Vol 17, Iss 10, Pp 1917-1920 (2011)
Emerging Infectious Diseases
Emerging Infectious Diseases
We tested 259 methicillin-resistant Staphylococcus aureus isolates and 2 USA300 ATCC type strains for susceptibility to bacitracin and neomycin contained in over-the-counter antibacterial ointments. Resistance to both bacitracin and neomycin was foun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3970d121580fd5166a09ed3ff3815789
https://doi.org/10.3201/eid1710.101365
https://doi.org/10.3201/eid1710.101365